Patents by Inventor Angelika Lüking

Angelika Lüking has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MARKER SEQUENCES FOR BREAST CANCER AND THE USE THEREOF
    Publication number: 20140371098
    Abstract: The present invention relates to a method for identifying marker sequences for breast cancer, the marker sequences identified with the aid of this method and diagnostic use thereof, diagnostic devices containing marker sequences for breast cancer, in particular an arrangement and a protein array, and use thereof. The invention also relates to method for the screening of potential active agents for the treatment and prevention of breast cancer by means of these marker sequences.
    Type: Application
    Filed: December 24, 2012
    Publication date: December 18, 2014
    Applicant: Protagen AG
    Inventors: Angelika Lüking, Axel Kowald, Annabel Höpner, Christian Scheer, Heidelinde Fiegl, Günter Daxenbichler
  • Novel Method for Diagnosis of High-Affinity Binders and Marker Sequences
    Publication number: 20140309133
    Abstract: The present invention relates to a novel method for diagnosing high-affinity binders, in particular antibodies or autoantibodies, and the identification, characterisation and selection of marker sequences and diagnostic use thereof, in particular in the form of a panel. The invention also relates to a singleplex assay in which the discovered selection of marker sequences is used in the form of a panel and high-affinity binders are detected using a single signal.
    Type: Application
    Filed: August 18, 2012
    Publication date: October 16, 2014
    Applicant: Protagen Aktinegesellschaft
    Inventors: Stefan Müllner, Peter Schulz-Knappe, Angelika Lueking, Heike Göhler, Jessica Schwermann
  • MARKER SEQUENCES FOR DIAGNOSING PROSTATE CANCER, AND USE THEREOF
    Publication number: 20140179557
    Abstract: The present invention relates to novel marker sequences for prostate carcinoma while excluding inflammatory prostate diseases or diabetes or polymorbidity and relates to their diagnostic use including a method for screening potential active substances for such prostate diseases by means of these marker sequences. The invention furthermore relates to a diagnostic device including such marker sequences for prostate carcinoma, in particular a protein biochip and its use.
    Type: Application
    Filed: February 24, 2014
    Publication date: June 26, 2014
    Applicant: PROTAGEN AKTIENGESELLSCHAFT
    Inventors: ANGELIKA LUEKING, AXEL KOWALD, HELMUT KLOCKER
  • MARKER SEQUENCES FOR MULTIPLE SCLEROSIS AND USE THEREOF
    Publication number: 20140018245
    Abstract: The invention relates to novel marker sequences for multiple sclerosis and to the use thereof in diagnosis as well as to a method for screening potential active ingredients for multiple sclerosis diseases using said marker sequences. The invention further relates to a diagnostic device containing such marker sequences for multiple sclerosis, especially to a protein biochip and the use thereof.
    Type: Application
    Filed: October 12, 2011
    Publication date: January 16, 2014
    Applicant: PROTAGEN Aktiengesellschaft
    Inventors: Angelika Lueking, Axel Kowald, Heike Göhler
  • MARKER SEQUENCES FOR SYSTEMIC LUPUS ERYTHEMATOSUS AND THE USE THEREOF
    Publication number: 20130303395
    Abstract: The invention relates to novel marker sequences for systemic lupus erythematosus and to the use thereof in diagnosis as well as to a method for screening potential active ingredients for systemic lupus erythematosus diseases using said marker sequences. The invention further relates to a diagnostic device containing such marker sequences for systemic lupus erythematosus, especially to a protein biochip and the use thereof.
    Type: Application
    Filed: October 12, 2011
    Publication date: November 14, 2013
    Applicant: PROTAGEN AKTIENGESELLSCHAFT
    Inventors: Angelika Lueking, Axel Kowald, Stefan Müllner, Christian Scheer, Matthias Schneider
  • Marker Sequences for Multiple Sclerosis and Use Thereof
    Publication number: 20130244897
    Abstract: The invention relates to novel marker sequences for multiple sclerosis and to the use thereof in diagnosis as well as to a method for screening potential active ingredients for multiple sclerosis diseases the marker sequences. The invention further relates to a diagnostic device containing such marker sequences for multiple sclerosis, especially to a protein biochip and the use thereof.
    Type: Application
    Filed: October 4, 2011
    Publication date: September 19, 2013
    Applicant: Protagen AG
    Inventors: Angelika Lueking, Axel Kowald, Heike Göhler
  • Marker Sequences for Inflammatory Prostate Diseases, Prostate Carconoma and Their Use
    Publication number: 20130217591
    Abstract: The present invention relates to novel marker sequences for inflammatory prostate diseases, prostate carcinoma and the diagnostic use thereof together with a method for screening of potential active substances for inflammatory prostate diseases, prostate carcinoma by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for inflammatory prostate diseases, prostate carcinoma, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: April 10, 2013
    Publication date: August 22, 2013
    Applicant: PROTAGEN AKTIENGESELLSCHAFT
    Inventors: HELMUT E. MEYER, ANGELIKA LUEKING, JENS BEATOR, AXEL KOWALD, GEORG BARTSCH, HELMUT KLOCKER
  • BIOMARKERS FOR ALZHEIMER'S DISEASE
    Publication number: 20130029864
    Abstract: The invention relates to novel marker sequences for Alzheimer's disease, in particular Alzheimer's dementia, and their diagnostic use including a screening method in order to identify potential drugs for the treatment/prophylaxis of Alzheimer's disease by means of the said novel marker sequences. Moreover, the invention relates to a diagnostic device comprising said novel marker sequences for diagnosing Alzheimer's disease, particularly a protein array (chip) and its use hereto.
    Type: Application
    Filed: October 1, 2010
    Publication date: January 31, 2013
    Applicant: PROTAGEN Aktiengesellschaft
    Inventors: Angelika Lueking, Stefan Müllner, Charlotte Teunissen, Jens Wiltfang
  • Marker Sequences for Pancreatic Cancer Diseases, Pancreatic Carcinoma and Use Thereof
    Publication number: 20120264634
    Abstract: The present invention relates to novel marker sequences for pancreatic cancer diseases, pancreatic carcinoma and the diagnostic use thereof together with a method for screening of potential active substances for pancreatic cancer diseases, pancreatic carcinoma by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for pancreatic cancer diseases, pancreatic carcinoma, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: September 29, 2010
    Publication date: October 18, 2012
    Applicant: PROTAGEN Aktiengesellschaft
    Inventors: Peter Amersdorfer, Annabel Höpfner, Angelika Lueking
  • MARKER SEQUENCE FOR NEURODEGENERATIVE DISEASES AND THE USE THEREOF
    Publication number: 20110184375
    Abstract: The present invention relates to new marker sequences for neurodegenerative diseases and the diagnostic use thereof together with a method for screening of potential active substances for neurodegenerative diseases by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for neurodegenerative diseases, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: December 22, 2008
    Publication date: July 28, 2011
    Applicant: Protagen Aktiengesellschaft
    Inventors: Heike Göhler, Helmut E. Meyer, Katrin Marcus, Axel Kowald, Florian Tribl, Manfred Gerlach, Peter Riederer, Angelika Lüking, Christian Scheer, Jens Beator
  • PROTEIN BIOCHIP FOR THE DIFFERENTIAL SCREENING OF PROTEIN-PROTEIN INTERACTIONS
    Publication number: 20100331201
    Abstract: The present invention relates to a system of protein binders containing at least one protein binder presented in at least one native form and at least one non-native form and its use including a method for discrimination and/or differential screening of suitable protein binders in native and non-native form.
    Type: Application
    Filed: June 11, 2007
    Publication date: December 30, 2010
    Applicant: PROTAGEN Aktiengesellschaft
    Inventors: Stefan Müllner, Angelika Lüking, Verena Trappe
  • MARKER SEQUENCES FOR MULTIPLE SCLEROSIS AND USE THEREOF
    Publication number: 20100280224
    Abstract: The present invention relates to new marker sequences for multiple sclerosis and the diagnostic use thereof together with a method for screening of potential active substances for multiple sclerosis by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for multiple sclerosis, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: September 3, 2008
    Publication date: November 4, 2010
    Applicant: Protagen AG
    Inventors: Jens Beator, Angelika Lüking, Axel Kowald, Helmut Meyer
  • MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS AND USE THEREOF
    Publication number: 20100261881
    Abstract: The present invention relates to new marker sequences for rheumatoid arthritis and the diagnostic use thereof together with a method for screening of potential active substances for rheumatoid arthritis by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for rheumatoid arthritis, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: September 3, 2008
    Publication date: October 14, 2010
    Applicant: Protagen AG
    Inventors: Jens Beator, Angelika Lüking, Axel Kowald, Helmut E. Meyer
  • METHOD FOR IMMUNOADSORPTION BY MEANS OF AUTOANITGENS
    Publication number: 20090246203
    Abstract: The invention relates to a novel method for immunoadsorption therapy of human autoimmune diseases by means of immobilized or fixed autoantigens.
    Type: Application
    Filed: January 24, 2007
    Publication date: October 1, 2009
    Inventors: Angelika Lüking, Christian Scheer, Verena Gruss Trappe, Claudia Gutjahr, Kirsten Schulte